Mucins reprogram stemness, metabolism and promote chemoresistance during cancer progression
Author:
Funder
National Cancer Institute
Nebraska Department of Health and Human Services
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
https://link.springer.com/content/pdf/10.1007/s10555-021-09959-1.pdf
Reference110 articles.
1. van Putten, J. P. M., & Strijbis, K. (2017). Transmembrane mucins: Signaling receptors at the intersection of inflammation and cancer. Journal of Innate Immunity, 9(3), 281–299. https://doi.org/10.1159/000453594.
2. Forstner, J. F. (1978). Intestinal mucins in health and disease. Digestion, 17(3), 234–263. https://doi.org/10.1159/000198115.
3. Kaur, S., Kumar, S., Momi, N., Sasson, A. R., & Batra, S. K. (2013). Mucins in pancreatic cancer and its microenvironment. Nature Reviews. Gastroenterology & Hepatology, 10(10), 607–620. https://doi.org/10.1038/nrgastro.2013.120.
4. Chaturvedi, P., Singh, A. P., & Batra, S. K. (2008). Structure, evolution, and biology of the MUC4 mucin. The FASEB Journal, 22(4), 966–981. https://doi.org/10.1096/fj.07-9673rev.
5. Dhanisha, S. S., Guruvayoorappan, C., Drishya, S., & Abeesh, P. (2018). Mucins: Structural diversity, biosynthesis, its role in pathogenesis and as possible therapeutic targets. Critical Reviews in Oncology/Hematology, 122, 98–122. https://doi.org/10.1016/j.critrevonc.2017.12.006.
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Clinicopathological characteristics and outcomes of colorectal mucinous adenocarcinoma: a retrospective analysis from China;Frontiers in Oncology;2024-02-06
2. Talniflumate abrogates mucin immune suppressive barrier improving efficacy of gemcitabine and nab-paclitaxel treatment in pancreatic cancer;Journal of Translational Medicine;2023-11-23
3. Defining a role for systemic chemotherapy in local and advanced appendix adenocarcinoma;ESMO Open;2023-10
4. Association of CDX2 and mucin expression with chemotherapeutic benefits in patients with stage II/III gastric cancer;Cancer Medicine;2023-08-21
5. Altered Glycosylation in Progression and Management of Bladder Cancer;Molecules;2023-04-13
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3